Cite Filings / LENZ / 0002052113-26-001098

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

LENZ Therapeutics, Inc. Filed 2026-10-27 Acc 0002052113-26-001098

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-04 SCHEDULE 13G Statement of Beneficial Ownership
2026-11-02 SCHEDULE 13D/A Beneficial Ownership Report
2026-11-02 4 Changes in Ownership
2026-10-28 8-K Results of operations · Exit or restructuring costs · Executive or director change
2026-10-27 SCHEDULE 13G Statement of Beneficial Ownership
2026-10-21 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-06-26 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…